SSA
RGNX icon

Schonfeld Strategic Advisors’s Regenxbio RGNX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Buy
+14,151
New +$149K ﹤0.01% 1855
2024
Q4 		– Sell
-124,632
Closed -$1.31M – 2328
2024
Q3 		$1.31M Buy
124,632
+75,512
+154% +$921K 0.01% 1065
2024
Q2 		$575K Sell
49,120
-134,675
-73% -$2.1M ﹤0.01% 1432
2024
Q1 		$3.87M Buy
+183,795
New +$3.27M 0.03% 735
2022
Q4 		– Sell
-7,578
Closed -$200K – 2943
2022
Q3 		$200K Buy
+7,578
New +$225K ﹤0.01% 2343
2019
Q4 		– Sell
-10,900
Closed -$387K – 1462
2019
Q3 		$387K Sell
10,900
-31,400
-74% -$1.27M 0.01% 718
2019
Q2 		$2.17M Sell
42,300
-46,800
-53% -$2.34M 0.08% 275
2019
Q1 		$5.11M Buy
+89,100
New +$4.41M 0.18% 155
2018
Q4 		– Sell
-25,700
Closed -$1.94M – 1209
2018
Q3 		$1.94M Sell
25,700
-84,200
-77% -$6.07M 0.09% 288
2018
Q2 		$7.89M Buy
109,900
+59,900
+120% +$2.86M 0.43% 52
2018
Q1 		$1.49M Sell
50,000
-108,687
-68% -$3.16M 0.11% 249
2017
Q4 		$5.28M Buy
158,687
+18,567
+13% +$559K 0.43% 62
2017
Q3 		$4.62M Buy
140,120
+65,120
+87% +$1.47M 0.42% 72
2017
Q2 		$1.48M Sell
75,000
-1,911
-2% -$37K 0.15% 199
2017
Q1 		$1.49M Buy
76,911
+36,911
+92% +$712K 0.15% 192
2016
Q4 		$742K Buy
+40,000
New +$764K 0.1% 270

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's RGNX Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Regenxbio (RGNX) in Q1 2026: 14,151 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #1855 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in RGNX as recently as Q3 2024.

Schonfeld Strategic Advisors first reported a position in RGNX in Q4 2016 and has held it in 16 quarters since. The position peaked at $7.89M in Q2 2018. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Schonfeld Strategic Advisors held 14,151 shares of Regenxbio worth $119K as of Q1 2026.
  • Regenxbio was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Regenxbio made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1855 holding.
  • Schonfeld Strategic Advisors first reported a position in Regenxbio in Q4 2016 and has held it in 16 quarters since.
  • Schonfeld Strategic Advisors's Regenxbio position peaked at $7.89M in Q2 2018.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.